rs80338759
Variant summary
Our verdict is Likely pathogenic. The variant received 9 ACMG points: 10P and 1B. PM2PP5_Very_StrongBP4
The NM_005120.3(MED12):c.3020A>G(p.Asn1007Ser) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. N1007N) has been classified as Likely benign.
Frequency
Consequence
NM_005120.3 missense
Scores
Clinical Significance
Conservation
Publications
- FG syndrome 1Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Orphanet
- MED12-related intellectual disability syndromeInheritance: XL Classification: DEFINITIVE Submitted by: ClinGen
- X-linked intellectual disability with marfanoid habitusInheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Orphanet
- blepharophimosis - intellectual disability syndrome, MKB typeInheritance: XL Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet
- cholestasis-pigmentary retinopathy-cleft palate syndromeInheritance: XL Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Likely_pathogenic. The variant received 9 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 23
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 23
ClinVar
Submissions by phenotype
X-linked intellectual disability with marfanoid habitus Pathogenic:2
- -
The observed missense variant c.3020A>G(p.Asn1007Ser) in MED12 gene has been reported previously in homozygous state in individuals with Nonsyndromic X-linked intellectual deficiency, Lujan syndrome (Bouazzi H, et al., 2015, Schwartz CE, et al., 2007). The c.3020A>G variant is absent in gnomAD Exomes. This variant has been reported to the ClinVar database as Pathogenic. However, experimental studies on the pathogenicity of the variant are not available. The amino acid Asparagine at position 1007 is changed to a Serine changing protein sequence and it might alter its composition and physico-chemical properties. Computational evidence (Polyphen-Benign, SIFT-Tolerated and Mutation Taster-Disease causing) predicts conflicting evidence on protein structure and function for this variant. The reference amino acid p.Asn1007Ser in MED12 is predicted as conserved by GERP++ and PhyloP across 100 vertebrates. For these reasons, this variant has been classified as Likely Pathogenic. -
not provided Pathogenic:2
- -
- -
FG syndrome Pathogenic:1
This sequence change replaces asparagine, which is neutral and polar, with serine, which is neutral and polar, at codon 1007 of the MED12 protein (p.Asn1007Ser). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with MED12-related conditions (PMID: 17369503, 23091001, 27980443). In at least one individual the variant was observed to be de novo. It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 11521). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is not expected to disrupt MED12 protein function with a negative predictive value of 95%. Experimental studies have shown that this missense change affects MED12 function (PMID: 23091001). For these reasons, this variant has been classified as Pathogenic. -
FG syndrome 1 Other:1
Recurrent variant in persons with Lujan syndrome -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at